PrEP

Pre-exposure prophylaxis, or PrEP, is a biomedical HIV prevention strategy that involves the use of antiretroviral medications by HIV-negative individuals to reduce their risk of HIV infection. PrEP involves taking a daily oral dose of Truvada® (Tenofovir disoproxil/emtricitabine), and many studies have shown the approach to be a safe and effective HIV prevention tool that can reduce the risk of acquiring HIV by over 90% when taken as prescribed. 

In spite of this effectiveness – and with medication on the market and clinical guidelines in place – access to PrEP remains limited, particularly among underserved populations, due to barriers such as provider resistance; lack of patient and provider education on PrEP; stigma directed at users of PrEP; and the cost burden for individuals (medications and copays) and for providers (funding PrEP services including lab tests and patient support and navigation, as well as supporting uninsured patients).

To help local health departments overcome these challenges, NACCHO has developed resources to strengthen local capacity to increase provider understanding of and community access to PrEP. 

Community Health

PrEP and Local Health Departments Educational Series

Pre-exposure prophylaxis, or PrEP, is an HIV prevention strategy.

Community Health

PrEP and Local Health Departments Educational Series

Community Health

PrEP Story Bank

Communities across the United States are at varying stages of PrEP awareness and implementation.

Community Health

PrEP Story Bank